Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication.

Published in: Alimentary pharmacology & therapeutics (2017)

The vonoprazan-based triple therapy showed superior efficacy in terms of H. pylori eradication as compared to the PPI-based triple therapy. In addition, the vonoprazan-based triple therapy showed comparable tolerability and incidence of adverse events.

Keyphrases

helicobacter pylori
helicobacter pylori infection
stem cells
risk factors
open label
small molecule
study protocol
protein protein